We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Response as an end point in treatment trials for acute GVHD.
- Authors
Pavletic, S Z
- Abstract
The author argues on that the studies have provided data that suggest day 28 as a suitable time point in measuring the response to first-line therapy in clinical trials for acute graft versus host disease (GVHD). The author stresses that the studies support the expert panel endorsement of day 28 response as a primary end point in acute GVHD treatment trials. The author stresses that additional data should be collected to extend its validation.
- Subjects
GRAFT versus host disease; CLINICAL trials; BONE marrow transplant complications; THERAPEUTICS
- Publication
Bone Marrow Transplantation, 2012, Vol 47, Issue 2, p161
- ISSN
0268-3369
- Publication type
Editorial
- DOI
10.1038/bmt.2011.59